Summary
- Current Price
- As of today, PBE price is $82.19, down -0.18% on
- Current Price vs All-Time High
- PBE price is currently -4.13% below its historical high of $85.73 set on
- Dividend Yield
- PBE current TTM dividend yield is 0.95%
- Next Ex-Dividend
- As of today, the next dividend for PBE has not been scheduled
Profile
| Metric | Value |
|---|---|
| Name | Invesco Biotechnology & Genome ETF |
| Assets Under Management | $265M |
| Expense Ratio | 0.58% |
| Asset Class | Equity |
| Domicile | US |
| Inception Date | |
| Net Asset Value | 83K USD |
| Website | invesco.com |
| Last Ex-Dividend Date | |
| Next Ex-Dividend Date | N/A |
Top 30 Holdings
| Name | Ticker | Weight |
|---|---|---|
| ILMN | 5.56% | |
| REGN | 5.05% | |
| BIIB | 5.05% | |
| UTHR | 4.94% | |
| INCY | 4.79% | |
| AMGN | 4.74% | |
| GILD | 4.63% | |
| ALNY | 4.42% | |
| FOLD | 3.78% | |
| DVAX | 3.53% | |
| MNKD | 3.07% | |
| ACAD | 2.95% | |
| BCRX | 2.92% | |
| BMRN | 2.85% | |
| COLL | 2.80% | |
| EXEL | 2.74% | |
| VCEL | 2.74% | |
| IONS | 2.72% | |
| QGEN | 2.67% | |
| TECH | 2.66% | |
| RPRX | 2.65% | |
| RGEN | 2.61% | |
| HALO | 2.55% | |
| CPRX | 2.52% | |
| PTCT | 2.52% | |
| NBIX | 2.51% | |
| TGTX | 2.49% | |
| MDGL | 2.48% | |
| VCYT | 2.44% | |
| PTGX | 2.40% |
Chart
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $82.19 | ||
| $72.30 | ||
| SMA 200 vs Price | -12.03% | |
| $82.29 | ||
| SMA 50 vs Price | +0.13% | |
| 0.71 | ||
| $1.04 | ||
| 49.54 | ||
| 18.34% | ||
| 22.07% |
Dividends
| Metric | Date | Value |
|---|---|---|
| $0.42 | ||
| N/A | N/A | |
| 0.95% | ||
| $0.78 |
Country Weights
| Country | Weight |
|---|---|
| United States | 97.30% |
| Netherlands | 2.68% |
Sector Weights
| Sector | Weight |
|---|---|
| Healthcare | 99.78% |
FAQ
Does PBE pay dividends?
Yes, the Invesco Biotechnology & Genome ETF does pays dividends, with the most recent payment being $0.42 per share. The last ex-dividend date was on December 22, 2025, and the next ex-dividend date has not been announced yet
What stocks are in PBE?
As of today, Invesco Biotechnology & Genome ETF includes 32 holdings, with 30 of them being companies from 2 different countries and 1 sectors. The most weighted holdings are Illumina, Inc. (5.56%), Regeneron Pharmaceuticals, Inc. (5.05%) and Biogen Inc. (5.05%)
What is the current assets under management for PBE?
Assets under management of Invesco Biotechnology & Genome ETF is $265M
What is PBE average volume?
Average volume of Invesco Biotechnology & Genome ETF is $8,291
What is PBE expense ratio?
Expense ratio of Invesco Biotechnology & Genome ETF is 0.58%
What is PBE inception date?
Inception date of Invesco Biotechnology & Genome ETF is June 23, 2005
Data Sources & References
- PBE Official Website www.invesco.com/content/invesco/us/en/financial-products/etfs/invesco-biotechnology-genome-etf.html
- PBE Profile on Yahoo Finance finance.yahoo.com/quote/PBE